Transfer of Large volume of Blood or Blood Products during surgeryâ?? Audit of current practices and post- surgery outcomes
Not Applicable
- Conditions
- Health Condition 1: C00-D49- Neoplasms
- Registration Number
- CTRI/2020/07/026654
- Lead Sponsor
- Tata Memorial Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients undergoing major surgeries with anticipated or unanticipated massive blood loss will be considered eligible.
Exclusion Criteria
-Age less than 18 years.
-Patients who are not willing to participate in the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method -To audit current practice of massive blood transfusion management in Tata Memorial Hospital. <br/ ><br>-To evaluate blood transfusion and coagulopathy management during massive blood loss.Timepoint: 1.Preoperative values (if available) -within 2 weeks before surgery. <br/ ><br>2.During surgery. <br/ ><br>3.Before shifting the patient out of the operation theatre. <br/ ><br>4.Immediately after the surgery in the recovery room/ICU. <br/ ><br>5.During the hospital stay.
- Secondary Outcome Measures
Name Time Method 1. Additional measures used for reducing blood loss such as tranexamic acid, factor 7a, prothrombin <br/ ><br>complex concentrate. <br/ ><br>2. Use of TEG and / or Coagulation profile for correction of coagulopathy. <br/ ><br>3. To evaluate postoperative organ dysfunction. <br/ ><br>4. To evaluate duration of ICU and postoperative hospital stay.Timepoint: 1.During surgery. <br/ ><br>2.Before shifting the patient out of the operation theatre. <br/ ><br>3.Immediately after the surgery in the recovery room/ICU. <br/ ><br>4.During the hospital stay.